Thursday, June 12, 2014
Publication and contact
nanoparticles could be useful for delivering combinations of cancer
therapeutics. The liposomes were coated with folate to facilitate cancer cell
targeting and loaded with Tarceva
in their hydrophobic regions and doxorubicin in their hydrophilic
regions. In mouse xenograft models of triple-negative breast cancer (TNBC)
and non-small cell lung cancer (NSCLC), the nanoparticles caused tumor
regression, whereas targeted, single-drug nanoparticles resulted in continued
tumor growth. In human TNBC and NSCLC cell lines, folate-targeted
liposomes loaded with doxorubicin or cisplatin
and various receptor
tyrosine kinase (RTK)
inhibitors generally showed greater cytotoxicity than liposomes containing
single drugs. Next steps could include evaluating the liposomal nanoparticles
for the delivery of additional combinations of cancer drugs.
Pharma Inc., Chugai
Pharmaceutical Co. Ltd. and Roche
market the small molecule epidermal
growth factor receptor (EGFR)
inhibitor Tarceva to treat liver cancer, pancreatic cancer and NSCLC.
Published online June 12, 2014
Patent application filed;
licensing status unavailable
Morton, S.W. et al. Sci.
Signal.; published online May 13, 2014;
Contact: Paula T. Hammond, Massachusetts Institute of
Technology, Cambridge, Mass.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]